alosetron has been researched along with Fecal Incontinence in 1 studies
alosetron : A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position.
Fecal Incontinence: Failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This article evaluates the characteristics and treatment patterns of female patients with severe diarrhea-predominant irritable bowel syndrome (IBS-D) who were treated with alosetron under a risk management program." | 3.78 | Evaluation of treatment continuation with alosetron by IBS-D severity criteria. ( Chuang, E; Nicandro, JP; Shin, P, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nicandro, JP | 1 |
| Shin, P | 1 |
| Chuang, E | 1 |
1 other study available for alosetron and Fecal Incontinence
| Article | Year |
|---|---|
Evaluation of treatment continuation with alosetron by IBS-D severity criteria.
Topics: Adolescent; Adult; Aged; Carbolines; Diarrhea; Fecal Incontinence; Female; Follow-Up Studies; Gastro | 2012 |